Radio-granular hydrogels for image-guided tumor brachytherapy  

作　　者：Shilong Shao Xiao Xu Gan Lin Gang Liu 

机构地区：[1]State Key Laboratory of Vaccines for Infectious Diseases,Center for Molecular Imaging and Translational Medicine,Xiang An Biomedicine Laboratory,National Innovation Platform for Industry-Education Integration in Vaccine Research,School of Public Health,Xiamen University,Xiamen 361005,Fujian Province,China [2]State Key Laboratory of Cellular Stress Biology,Innovation Center for Cell Biology,School of Life Sciences,Xiamen University,Xiamen 361005,Fujian Province,China [3]Innovation Laboratory for Sciences and Technologies of Energy Materials of Fujian Province(IKKEM)&Amoy Hopeful Biotechnology Co.,Ltd.,Xiamen 361028,Fujian Province,China

出　　处：《iLIVER》2023年第3期177-179,共3页国际肝胆健康（英文）

摘　　要：Transarterial radioembolization(TARE),derived from transarterial chemoembolization,embolizes tumor blood vessels and elicits tumor brachytherapy by using radionuclide-loaded microspheres,a promising therapeutic modality for locally advanced hepatocellular carcinoma(HCC)[1,2].However,the implementation of TARE in the clinic has been hampered by the lack of efficient radioembolization agents[3,4].

关 键 词：Hepatocellular carcinoma TARE Conversion therapy THERANOSTICS 

分 类 号：R735.7[医药卫生—肿瘤]